HOME >> MEDICINE >> NEWS
Acrux reports progress in development of Testosterone MD-Lotion(R) for men

Acrux Limited (ASX: ACR), the Australian pharmaceutical company which specialises in administering drugs through the skin, today announced positive results from two more clinical studies of its Testosterone MD-Lotion treatment for testosterone deficiency in men, which is associated with a number of symptoms including lethargy, depression and reduced libido. Both studies were conducted at the Centre for Clinical Studies, Melbourne, with Professor Susan Davis supervising as Principal Investigator.

The studies compared blood levels of testosterone in healthy volunteers. The aim of the first study was to compare two different formulations of Testosterone MD Lotion, and the aim of the second study was to compare two different application sites.

The results of the first study showed that both formulations provided similar blood levels, providing options for continued development of either formulation. In the second study, there was a significant difference in absorption between the two different application sites, providing important information for the design of the remaining clinical studies in men.

In both studies, the lotion was well tolerated, with no application site reactions noted, and no serious adverse events recorded. Full details of the studies are presented in Appendix 1.

Acrux's development of Testosterone MD Lotion is continuing, with further studies to commence shortly to confirm the doses required to maintain testosterone blood levels in the target range for effective treatment.

Acrux CEO and Managing Director, Dr Igor Gonda said: "We believe our fast drying, no-touch metered dose lotion has significant competitive advantage over the existing products in this growing market. The remaining trials suit our expertise and require moderate investment, so in line with our financial plans we intend to complete them ourselves before choosing the best option for sales and marketing".

The remaining development prog
'"/>

Contact: Igor Gonda
61-383-790-100
Research Australia
7-Sep-2005


Page: 1 2

Related medicine news :

1. Acrux completes enrollment in key phase 2 trial
2. Acrux and Oreganon further expand their collaboration
3. Acrux granted first grant in Europe, triggering payment from Lilly
4. Acrux patent portfolio advances in USA
5. Acrux acquires rights to commercialise worlds first contraceptive spray
6. Four new us patents granted to Acrux for transdermal drug delivery
7. New study reports hotel guests at risk from carbon monoxide poisoning
8. MIT reports key pathway in synaptic plasticity
9. ENDEAVOR III Trial reports key findings on new-generation stent
10. New study reports improved treatment and reduced mortality for patients with heart failure
11. Study reports changing to a low-fat diet can induce stress

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:10/16/2018)... ... October 16, 2018 , ... ... it will host the proceedings of the 4th Annual International HPV Vaccine Education ... that runs Wednesday, May 22, 2019, through Friday, May 24, 2019, with a ...
(Date:10/13/2018)... ... October 12, 2018 , ... Convoy of Hope is ... trucks and a disaster service team to the devastated Florida Panhandle to begin response ... to help Convoy’s disaster response teams and provide supplies to those affected by the ...
(Date:10/13/2018)... ... October 13, 2018 , ... ... Fitness & Nutrition, has announced LaRhonda Burley as its new Vice President of ... in 2010 to support and strengthen the mission of the President's Council by ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... diverse range of healthcare organizations nationwide, announced today the launch of its new ... the Company’s portfolio of services while offering a more comprehensive understanding of the ...
(Date:10/7/2018)... ... October 07, 2018 , ... ... on today’s issues affecting humanity at practical and spiritual levels. Founder of the ... sacred program of ‘Special Prayers’, inspired by Navratri, is a mystical time when ...
Breaking Medicine News(10 mins):
(Date:10/13/2018)... ... October 12, 2018 , ... In the aftermath ... open and has hotel availability for anyone in need, and the Pensacola International ... Northwest Florida. In the aftermath, Pensacola is open and has hotel availability for ...
(Date:10/11/2018)... ... October 11, 2018 , ... ... today that it has completed the strategic combination of RevSpring and Apex ... revenue cycle engagement, billing, and payments solutions generating over one billion consumer ...
(Date:10/7/2018)... ... 07, 2018 , ... No one likes to think about an emergency, even what might seem ... a family. The local ServPro professional, a trusted leader in the restoration industry, has a ... , No time is a good time for an emergency, but having a few ...
Breaking Medicine Technology:
Cached News: